Section: Aquatic Bacteria

Aeromonas hydrophila in Farmed Fish: Pathogenesis and Antimicrobial Resistance

Introduction

Aeromonas hydrophila is a Gram-negative, facultatively anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is a ubiquitous inhabitant of aquatic environments, including freshwater and brackish water systems, and is a primary etiological agent of hemorrhagic septicemia in a wide range of farmed fish species. The bacterium is considered an opportunistic pathogen, causing disease outbreaks particularly when fish are subjected to environmental stressors such as poor water quality, high stocking densities, temperature fluctuations, and concurrent infections. The economic impact of A. hydrophila on global aquaculture is substantial, affecting species including tilapia, catfish, carp, trout, and salmon. This review provides a detailed examination of the pathogenesis of A. hydrophila in farmed fish, the clinical and pathological manifestations of disease, diagnostic approaches, and the escalating challenge of antimicrobial resistance (AMR) in aquaculture settings.

Taxonomy and Strain Diversity

Aeromonas hydrophila is classified within the genus Aeromonas, which comprises over 30 species. The species A. hydrophila is further subdivided into several subspecies, including A. hydrophila subsp. hydrophila and A. hydrophila subsp. dhakensis (formerly Aeromonas aquariorum). Strain-level diversity is significant, with variations in virulence gene carriage, serotype, and antimicrobial susceptibility profiles. Molecular typing methods, including multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE), have revealed considerable genetic heterogeneity among isolates from different geographic regions and fish hosts. This genetic diversity complicates vaccine development and the prediction of pathogenic potential.

Pathogenesis and Virulence Factors

The pathogenesis of A. hydrophila infection is multifactorial, involving a complex array of virulence determinants that facilitate adhesion, invasion, toxin-mediated tissue damage, and immune evasion. The bacterium can infect fish through the gills, skin abrasions, and the gastrointestinal tract.

Adhesion and Colonization

Initial colonization requires adherence to host epithelial surfaces. A. hydrophila produces several adhesins, including type IV pili, which mediate attachment to fish intestinal and gill epithelial cells. The bacterium also expresses outer membrane proteins (OMPs) and lipopolysaccharide (LPS) that contribute to adhesion and biofilm formation. Biofilm formation is a critical survival strategy, allowing the bacterium to persist in aquatic environments and on aquaculture infrastructure, and is regulated by quorum sensing systems.

Toxin Production

A hallmark of A. hydrophila virulence is the secretion of potent exotoxins. The major toxins include:

  • Aerolysin (AerA): A pore-forming toxin that binds to host cell membranes, oligomerizes, and forms transmembrane channels. This leads to osmotic lysis of erythrocytes, leukocytes, and epithelial cells. Aerolysin is a key factor in the development of hemorrhagic lesions.
  • Hemolysins (HlyA, HlyB): These toxins also disrupt host cell membranes, contributing to hemolysis and tissue necrosis.
  • Cytotoxic enterotoxin (Act): A type II secretion system effector with both cytotoxic and enterotoxic activities, causing fluid accumulation in the gut and epithelial cell death.
  • Heat-labile and heat-stable enterotoxins: These contribute to the diarrheal component of the disease.

Extracellular Enzymes

A. hydrophila secretes a suite of hydrolytic enzymes that degrade host tissues and facilitate systemic dissemination. These include:

  • Proteases (e.g., serine protease, metalloprotease): Degrade host connective tissue proteins, including collagen and elastin, facilitating bacterial spread.
  • Lipases: Hydrolyze lipids, contributing to tissue necrosis.
  • DNases: Degrade host DNA, potentially aiding in immune evasion.
  • Amylases and chitinases: Allow utilization of environmental nutrients.

Iron Acquisition Systems

Iron is essential for bacterial growth. A. hydrophila possesses multiple iron acquisition systems, including siderophores (e.g., amonabactin, enterobactin) and heme uptake systems. These systems allow the bacterium to scavenge iron from host transferrin and hemoglobin, which is critical for survival within the iron-limited environment of the fish host.

Immune Evasion Mechanisms

The bacterium employs several strategies to subvert the host immune response. The LPS O-antigen can vary, contributing to serological diversity and resistance to complement-mediated killing. The capsule polysaccharide also provides protection against phagocytosis. Furthermore, A. hydrophila can survive and replicate within macrophages, a feature that facilitates systemic spread and chronic infection.

Clinical Signs and Pathology

The clinical presentation of A. hydrophila infection in farmed fish is broadly characterized as hemorrhagic septicemia. The severity of disease depends on host susceptibility, bacterial strain virulence, and environmental conditions.

Acute Disease

In acute outbreaks, fish may exhibit sudden mortality with few premonitory signs. Clinical signs include:

  • Cutaneous hemorrhages: Petechiae and ecchymoses on the body surface, fins, and opercula.
  • Exophthalmia: Bilateral or unilateral protrusion of the eyes.
  • Abdominal distension: Due to ascites (fluid accumulation in the peritoneal cavity).
  • Anemia: Pale gills and lethargy.
  • Ulcerative lesions: Focal areas of skin necrosis that can progress to deep, crateriform ulcers, exposing underlying muscle.

Chronic Disease

Chronic infections may present with less severe signs, including reduced feed intake, erratic swimming, and slow growth. Internal examination often reveals:

  • Serosanguinous ascitic fluid: A pinkish or bloody fluid in the peritoneal cavity.
  • Petechial hemorrhages on internal organs: Particularly on the liver, spleen, kidney, and swim bladder.
  • Splenomegaly and renomegaly: Enlargement of the spleen and kidney.
  • Enteritis: Inflammation and congestion of the intestinal tract.

Histopathology

Histological examination reveals extensive tissue necrosis and hemorrhage. In the liver, there is hepatocellular degeneration and necrosis with multifocal hemorrhages. The kidney shows tubular necrosis and interstitial inflammation. The spleen exhibits lymphoid depletion and necrosis. In the gills, lamellar edema, epithelial lifting, and necrosis are observed. The presence of bacterial colonies within tissues is a common finding.

Diagnostic Approaches

Accurate and timely diagnosis is essential for implementing control measures. A combination of clinical observation, necropsy findings, and laboratory testing is employed.

Culture-Based Diagnosis

Isolation of A. hydrophila from affected tissues (kidney, spleen, liver, brain, or ascitic fluid) remains the gold standard. Samples are plated on general-purpose media such as tryptic soy agar (TSA) or blood agar. Selective media, such as Rimler-Shotts agar or Aeromonas selective agar (ASA), can be used to suppress competing flora. Colonies typically appear as round, smooth, and convex, often with a characteristic odor. On blood agar, beta-hemolysis is commonly observed.

Biochemical identification is performed using commercial identification systems (e.g., API 20E strips) or traditional biochemical tests. Key biochemical characteristics of A. hydrophila include:

  • Oxidase positive
  • Catalase positive
  • Glucose fermenter
  • Motile (polar flagella)
  • Indole positive
  • Voges-Proskauer positive
  • Resistance to the vibriostatic agent O/129

Molecular Diagnostics

Molecular methods offer higher sensitivity and specificity compared to culture, particularly for detecting carrier states or mixed infections.

  • Conventional PCR: Targets species-specific genes such as aerA (aerolysin), hlyA (hemolysin), gcat (cytotoxic enterotoxin), and the 16S rRNA gene. Multiplex PCR assays can simultaneously detect multiple virulence genes.
  • Quantitative PCR (qPCR): Provides quantification of bacterial load in tissues and water samples. This is useful for monitoring infection intensity and environmental contamination.
  • Loop-mediated isothermal amplification (LAMP): A rapid, field-deployable method that does not require a thermocycler. LAMP assays targeting the aerA gene have been developed for point-of-care diagnostics.
  • Whole genome sequencing (WGS): Used for high-resolution typing, virulence gene profiling, and AMR gene detection. WGS is increasingly important for epidemiological surveillance and outbreak investigations.

Serological Methods

Serological assays, such as the Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus (as a methodological parallel), can be adapted for antigen detection in fish tissues. However, these are less commonly used for routine A. hydrophila diagnosis compared to culture and PCR. Antibody detection in surviving fish can indicate prior exposure but is not useful for diagnosing active infections.

Diagnostic Algorithm

The following Mermaid diagram outlines a typical diagnostic workflow for suspected A. hydrophila infection in farmed fish.

flowchart TD
    A[Clinical Signs: Hemorrhagic Septicemia, Ulcers, Ascites], > B[Fish Necropsy & Gross Pathology]
    B, > C[Sample Collection: Kidney, Spleen, Liver, Ascitic Fluid]
    C, > D[Gram Stain: Gram-Negative Rods]
    D, > E[Primary Culture on TSA or Blood Agar]
    E, > F[Selective Media: Rimler-Shotts Agar]
    F, > G[Biochemical Identification: Oxidase +, API 20E]
    G, > H[Confirmation: PCR for aerA or 16S rRNA]
    H, > I[Antimicrobial Susceptibility Testing: Disk Diffusion or Broth Microdilution]
    I, > J[Report: Species Confirmed, Virulence Profile, AMR Pattern]

Antimicrobial Resistance

The widespread use of antibiotics in aquaculture for prophylaxis and treatment has driven the emergence and dissemination of antimicrobial resistance in A. hydrophila. This poses a significant threat to fish health, treatment efficacy, and potentially to public health through the food chain and environmental contamination.

Mechanisms of Resistance

A. hydrophila employs a diverse arsenal of resistance mechanisms, often encoded on mobile genetic elements such as plasmids, integrons, and transposons.

  • Beta-lactam resistance: The most common mechanism is the production of beta-lactamases. A. hydrophila harbors both chromosomal and plasmid-mediated beta-lactamases, including class A (e.g., TEM, SHV), class B (metallo-beta-lactamases, e.g., IMP, VIM), class C (AmpC), and class D (OXA) enzymes. This confers resistance to penicillins, cephalosporins, and carbapenems.
  • Tetracycline resistance: Mediated by efflux pumps (e.g., TetA, TetB, TetE) and ribosomal protection proteins (e.g., TetM, TetO). The tet genes are frequently located on mobile elements.
  • Quinolone and fluoroquinolone resistance: Arises from mutations in the quinolone resistance-determining regions (QRDRs) of DNA gyrase (gyrA) and topoisomerase IV (parC). Plasmid-mediated quinolone resistance (PMQR) genes, such as qnrS and aac(6')-Ib-cr, have also been identified.
  • Aminoglycoside resistance: Mediated by aminoglycoside-modifying enzymes (AMEs) including acetyltransferases, phosphotransferases, and adenylyltransferases. The aac(3)-II and aadA genes are commonly reported.
  • Chloramphenicol resistance: Primarily due to the production of chloramphenicol acetyltransferase (CAT), encoded by cat genes.
  • Sulfonamide and trimethoprim resistance: Mediated by alternative dihydropteroate synthase (sul1, sul2) and dihydrofolate reductase (dfrA) genes, respectively.
  • Multidrug resistance (MDR): The co-occurrence of multiple resistance genes on the same mobile element is common, leading to MDR phenotypes. Efflux pumps, such as those belonging to the resistance-nodulation-division (RND) family (e.g., AdeABC homologs), can also contribute to MDR by extruding a broad range of antibiotics.

Resistance Patterns in Aquaculture

Surveillance studies from major aquaculture regions have documented high prevalence of resistance to commonly used antibiotics. The table below summarizes typical resistance patterns observed in A. hydrophila isolates from farmed fish.

| Antibiotic Class | Example Agents | Common Resistance Prevalence | Primary Resistance Mechanism | | :-, | :-, | :-, | :-, | | Beta-lactams | Amoxicillin, Oxytetracycline | High (often >50%) | Beta-lactamases (TEM, OXA, AmpC) | | Tetracyclines | Oxytetracycline, Doxycycline | Moderate to High (30-70%) | Efflux pumps (TetA, TetB) | | Quinolones | Oxolinic acid, Flumequine | Moderate (20-50%) | QRDR mutations, PMQR genes | | Phenicols | Florfenicol | Low to Moderate (10-30%) | Efflux pumps (FloR), CAT enzymes | | Sulfonamides | Sulfadiazine, Sulfamethoxazole | High (often >50%) | Alternative DHPS (Sul1, Sul2) | | Aminoglycosides | Gentamicin, Streptomycin | Low to Moderate (10-40%) | Aminoglycoside-modifying enzymes |

Drivers of Resistance

Several factors contribute to the high levels of AMR in aquaculture:

  • Overuse and misuse of antibiotics: Prophylactic use at subtherapeutic doses in feed is a major driver.
  • Environmental persistence: Antibiotics and resistance genes persist in sediment and water, creating a reservoir for horizontal gene transfer.
  • Biofilm formation: Biofilms facilitate the exchange of mobile genetic elements and protect bacteria from antibiotics.
  • Co-selection: The use of metals (e.g., copper, zinc) in aquaculture feeds can co-select for antibiotic resistance genes located on the same mobile elements.

Implications for Treatment and Control

The emergence of MDR A. hydrophila severely limits therapeutic options. Antimicrobial susceptibility testing (AST) is critical for guiding treatment. Disk diffusion and broth microdilution methods, following standardized guidelines (e.g., CLSI VET04), should be performed on representative isolates. In many cases, only a few agents, such as florfenicol or certain fluoroquinolones, retain efficacy. The development of alternative control strategies, including vaccines, probiotics, and improved biosecurity, is urgently needed.

Control and Prevention

A holistic approach is required to manage A. hydrophila infections and mitigate AMR.

  • Biosecurity: Strict quarantine protocols for new stock, disinfection of equipment, and control of water quality parameters (temperature, dissolved oxygen, ammonia) are fundamental.
  • Vaccination: Autogenous and commercial vaccines are available for some fish species. Vaccines based on inactivated whole cells, OMPs, or recombinant toxins (e.g., aerolysin) have shown variable efficacy. The development of effective, multivalent vaccines remains a research priority.
  • Probiotics and prebiotics: The use of beneficial bacteria (e.g., Bacillus spp., Lactobacillus spp.) to competitively exclude pathogens and modulate the host immune response is a promising strategy.
  • Antimicrobial stewardship: Implementing AST before treatment, using narrow-spectrum agents when possible, and adhering to recommended dosages and withdrawal periods are essential to slow the spread of resistance.

Conclusion

Aeromonas hydrophila remains a formidable pathogen in global aquaculture, causing significant economic losses through hemorrhagic septicemia. Its pathogenesis is driven by a sophisticated arsenal of adhesins, toxins, and immune evasion factors. The escalating crisis of antimicrobial resistance, particularly the emergence of MDR strains, threatens the sustainability of fish farming. Robust diagnostic protocols that integrate culture, molecular detection, and AST are essential for effective disease management. Future efforts must focus on developing non-antibiotic control strategies, including effective vaccines and probiotics, and implementing stringent antimicrobial stewardship programs to preserve the efficacy of existing therapeutic agents.

References

  1. Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010;23(1):35-73.
  2. Austin B, Austin DA. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish. 6th ed. Springer; 2016.
  3. Cipriano RC, Bullock GL, Pyle SW. Aeromonas hydrophila and motile aeromonad septicemias of fish. Fish Dis Leaflet 68. US Fish and Wildlife Service; 1984.
  4. Pridgeon JW, Klesius PH. Virulence of Aeromonas hydrophila to channel catfish Ictalurus punctatus fingerlings. Vet Microbiol. 2011;150(3-4):381-387.
  5. Zhang X, Yang W, Wu H, et al. Multilocus sequence typing reveals a high genetic diversity of Aeromonas hydrophila strains isolated from freshwater fish in China. J Fish Dis. 2014;37(8):719-727.
  6. Beaz-Hidalgo R, Figueras MJ. Aeromonas spp. whole genomes and virulence factors implicated in fish disease. J Fish Dis. 2013;36(4):371-388.
  7. Chopra AK, Houston CW. Enterotoxins in Aeromonas-associated gastroenteritis. Microbes Infect. 1999;1(13):1129-1137.
  8. Howard SP, Garland WJ, Green MJ, Buckley JT. Nucleotide sequence of the gene for the hole-forming toxin aerolysin of Aeromonas hydrophila. J Bacteriol. 1987;169(6):2869-2871.
  9. Ferguson MR, Xu XJ, Houston CW, et al. Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila. Infect Immun. 1997;65(10):4299-4308.
  10. Cascón A, Yugueros J, Temprano A, et al. A major secreted elastase is essential for pathogenicity of Aeromonas hydrophila. Infect Immun. 2000;68(6):3233-3241.
  11. Pemberton JM, Kidd SP, Schmidt R. Secreted enzymes of Aeromonas. FEMS Microbiol Lett. 1997;152(1):1-10.
  12. Byers BR, Massad G, Barghouthi S, Arceneaux JE. Iron acquisition in the motile aeromonads. Biometals. 1991;4(3):152-158.
  13. Telford G, Wheeler D, Williams P, et al. The Aeromonas hydrophila iron acquisition system: a target for novel antimicrobials. J Antimicrob Chemother. 1998;41(1):15-24.
  14. Merino S, Rubires X, Aguilar A, Tomás JM. The role of the O-antigen lipopolysaccharide on the serum resistance of Aeromonas hydrophila. FEMS Microbiol Lett. 1996;139(2-3):175-180.
  15. Zhang Y, Arias CR. Identification and characterization of an Aeromonas hydrophila oligopeptidase gene. FEMS Microbiol Lett. 2007;270(2):237-243.
  16. Noga EJ. Fish Disease: Diagnosis and Treatment. 2nd ed. Wiley-Blackwell; 2010.
  17. Roberts RJ. Fish Pathology. 4th ed. Wiley-Blackwell; 2012.
  18. Shotts EB, Rimler R. Medium for the isolation of Aeromonas hydrophila. Appl Microbiol. 1973;26(4):550-553.
  19. Abbott SL, Cheung WK, Janda JM. The genus Aeromonas: biochemical characteristics, API 20E system, and phenotypic identification. J Clin Microbiol. 2003;41(6):2348-2357.
  20. Kingombe CI, Huys G, Tonolla M, et al. PCR detection, characterization, and distribution of virulence genes in Aeromonas spp. Appl Environ Microbiol. 1999;65(12):5293-5302.
  21. Nawaz M, Khan SA, Khan AA, et al. Detection and characterization of virulence genes and integrons in Aeromonas veronii isolated from catfish. Food Microbiol. 2010;27(3):327-331.
  22. Balboa S, Romalde JL. Multiplex PCR for detection of virulence genes in Aeromonas spp. from fish. J Fish Dis. 2013;36(10):871-879.
  23. González-Serrano CJ, Santos JA, García-López ML, Otero A. Virulence markers in Aeromonas hydrophila and Aeromonas veronii biovar sobria isolates from freshwater fish and from a diarrhoea case. J Appl Microbiol. 2002;93(3):414-419.
  24. Puthucheary SD, Puah SM, Chua KH. Molecular characterization of clinical isolates of Aeromonas species from Malaysia. PLoS One. 2012;7(2):e30205.
  25. Martino ME, Fasolato L, Montemurro F, et al. Determination of antimicrobial resistance and virulence gene profiles in Aeromonas spp. isolated from retail fish. Int J Food Microbiol. 2011;148(2):117-123.
  26. Jacobs L, Chenia HY. Characterization of integrons and tetracycline resistance determinants in Aeromonas spp. isolated from South African aquaculture systems. Int J Food Microbiol. 2007;114(3):295-306.
  27. Schmidt AS, Bruun MS, Dalsgaard I, Larsen JL. Incidence, distribution, and spread of tetracycline resistance determinants and integron-associated antibiotic resistance genes among motile aeromonads from a fish farming environment. Appl Environ Microbiol. 2001;67(12):5675-5682.
  28. Goni-Urriza M, Capdepuy M, Arpin C, et al. Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Appl Environ Microbiol. 2000;66(1):125-132.
  29. Gordon L, Giraud E, Ganière JP, et al. Antimicrobial resistance survey in Aeromonas hydrophila strains isolated from fish in France. J Fish Dis. 2007;30(4):231-238.
  30. Saavedra MJ, Guedes-Novais S, Alves A, et al. Resistance to beta-lactam antibiotics in Aeromonas hydrophila isolated from rainbow trout (Oncorhynchus mykiss). Int Microbiol. 2004;7(3):207-211.
  31. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother. 2010;54(1):24-38.
  32. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005;18(2):306-325.
  33. Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett. 2005;245(2):195-203.
  34. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51(5):1109-1117.
  35. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6(10):629-640.
  36. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev. 1993;57(1):138-163.
  37. Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev. 2004;28(5):519-542.
  38. Sköld O. Sulfonamide resistance: mechanisms and trends. Drug Resist Updat. 2000;3(3):155-160.
  39. Huys G, Cnockaert M, Bartie K, et al. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Aeromonas hydrophila strains from fish culture systems. Microb Drug Resist. 2005;11(3):229-236.
  40. Akinbowale OL, Peng H, Barton MD. Antimicrobial resistance in bacteria isolated from aquaculture sources in Australia. J Appl Microbiol. 2006;100(5):1103-1113.
  41. Sørum H. Antimicrobial drug resistance in fish pathogens. In: Aarestrup FM, ed. Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press; 2006:213-238.
  42. Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006;8(7):1137-1144.
  43. Heuer OE, Kruse H, Grave K, et al. Human health consequences of use of antimicrobial agents in aquaculture. Clin Infect Dis. 2009;49(8):1248-1253.
  44. Smith P. Antimicrobial resistance in aquaculture. Rev Sci Tech. 2008;27(1):243-264.
  45. CLSI. Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals. CLSI guideline VET04. 2nd ed. Clinical and Laboratory Standards Institute; 2014.
  46. Sommerset I, Krossøy B, Biering E, Frost P. Vaccines for fish in aquaculture. Expert Rev Vaccines. 2005;4(1):89-101.
  47. Gudding R, Lillehaug A, Evensen Ø. Recent developments in fish vaccinology. Vet Immunol Immunopathol. 1999;72(1-2):203-212.
  48. Irianto A, Austin B. Probiotics in aquaculture. J Fish Dis. 2002;25(11):633-642.
  49. Verschuere L, Rombaut G, Sorgeloos P, Verstraete W. Probiotic bacteria as biological control agents in aquaculture. Microbiol Mol Biol Rev. 2000;64(4):655-671.
  50. Defoirdt T, Sorgeloos P, Bossier P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr Opin Microbiol. 2011;14(3):251-258.